Risk Factors for the Presence and Progression of Cardiovascular Autonomic Neuropathy in Type 2 Diabetes: ADDITION-Denmark
The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To examine the course of cardiovascular autonomic neuropathy (CAN) and related cardiometabolic risk factors in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS: CAN and cardiometabolic risk factors were assessed in the Danish arm of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Denmark) at 6-year (n = 777) and 13-year (n = 443) follow-up examinations. Cardiovascular autonomic reflex tests (CARTs)—that is, lying to standing, deep breathing, and the Valsalva maneuver—and 2-min resting heart rate variability (HRV) indices were obtained as the main measures of CAN. Risk factors related to CAN status, as determined by CARTs, were studied by using multivariate logistic regressions. The effects of risk factors on continuous CARTs and HRV indices, and their changes over time, were estimated in linear mixed models. RESULTS: A progressive yet heterogeneous course of CAN occurred between the 6- and 13-year follow-ups. Higher HbA1c, weight, BMI, and triglycerides were associated with prevalent CAN. No significant effect of risk factors on CARTs was found when they were analyzed as continuous variables. CART indices decreased over time, and a trend of decreasing HRV indices was seen. Higher HbA1c and BMI were associated with lower HRV index values, but these differences diminished over time. CONCLUSIONS: These data confirm that hyperglycemia, obesity, and hypertriglyceridemia are negatively related to indices of CAN, although these effects diminish over time. The observed heterogeneous course of CAN may challenge the present clinical approach of categorically classifying CARTs to diagnose CAN and the notion of CAN being irreversible.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Diabetic macular edema in the absence of proliferative retinopathy is most commonly treated with repeated anti-VEGF injections.541”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [541]
Citations
Cites
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Heart Rate Variability: Standards of Measurement, Physiological Interpretation, and Clinical Use
Electrophysiology, T. F. O. T. E. S. O. C. T. N. A. (1996) · Circulation · doi:10.1161/01.cir.93.5.1043 · Cited by 17,159
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762 · cited 1×
“No clear evidence supports glucoselowering intervention to prevent CAN in type 2 diabetes (14,15).”
BackgroundTesfaye, S., Boulton, A. J. M., Dyck, P. J., Freeman, R., Horowitz, M., Kempler, P., Lauria, G., Malik, R. A., Spallone, V., Vinik, A., et al. (2010) · Diabetes Care · doi:10.2337/dc10-1303 · Cited by 2,690
Diabetic neuropathy: A position statement by the American Diabetes Association
Pop-Busui, R., Boulton, A. J. M., Feldman, E. L., Bril, V., Freeman, R., Malik, R. A., Sosenko, J. M., & Ziegler, D. (2017) · Diabetes Care · doi:10.2337/dc16-2042 · Cited by 2,602 · cited 5×
“Albuminuria was associated with CAN at the 6-year follow-up, which is in line with previous research (1).”
BackgroundResultInfluentialSelf-citationThe Value of Cardiovascular Autonomic Function Tests: 10 Years Experience in Diabetes
Ewing, D. J., Martyn, C. N., Young, R. J., & Clarke, B. F. (1985) · Diabetes Care · doi:10.2337/diacare.8.5.491 · Cited by 1,434
Diabetic cardiovascular autonomic neuropathy
Vinik, A. I., & Ziegler, D. (2007) · Circulation · doi:10.1161/circulationaha.106.634949 · Cited by 1,255
Gæde, P., Vedel, P., Parving, H.-H., & Pedersen, O. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07368-1 · Cited by 981 · cited 5×
“opment of CAN among participants with type 2 diabetes and albuminuria who received similar treatment (16).”
BackgroundResultInfluentialSpallone, V., Ziegler, D., Freeman, R., Bernardi, L., Frontoni, S., Pop‐Busui, R., Stevens, M., Kempler, P., Hilsted, J., Tesfaye, S., et al. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1239 · Cited by 957
Self-citationMaser, R. E., Mitchell, B. D., Vinik, A. I., & Freeman, R. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1895 · Cited by 578
Pop-Busui, R., Evans, G. W., Gerstein, H. C., Fonseca, V., Fleg, J. L., Hoogwerf, B. J., Genuth, S., Grimm, R. H., Corson, M. A., Prineas, R., et al. (2010) · Diabetes Care · doi:10.2337/dc10-0125 · Cited by 540
Self-citationGriffin, S. J., Borch-Johnsen, K., Davies, M. J., Khunti, K., Rutten, G. E., Sandbæk, A., Sharp, S. J., Simmons, R. K., van den Donk, M., Wareham, N. J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60698-3 · Cited by 462 · cited 1×
“General practices were randomized to deliver either intensive, target-driven, multifactorial care or routine care until the trial concluded in 2009 (;6 years after inclusion) (19,20).”
MethodSelf-citationHerman, W. H., Ye, W., Griffin, S. J., Simmons, R. K., Davies, M. J., Khunti, K., Rutten, G. E. H. M., Sandbaek, A., Lauritzen, T., Borch-Johnsen, K., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2459 · Cited by 340 · cited 1×
“have preceded a clinical presentation of diabetes by 3–5 years, equaling the diabetes duration of this cohort, to 8–10 years in cohorts with clinically diagnosed diabetes (30).”
BackgroundSelf-citationAutonomic Symptoms and Diabetic Neuropathy
Low, P. A., Benrud-Larson, L. M., Sletten, D. M., Opfer-Gehrking, T. L., Weigand, S. D., O’Brien, P. C., Suarez, G. A., & Dyck, P. J. (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2942 · Cited by 319
Glucose Control and Diabetic Neuropathy: Lessons from Recent Large Clinical Trials
Ang, L., Jaiswal, M., Martin, C., & Pop-Busui, R. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0528-7 · Cited by 303 · cited 2×
“Few longitudinal studies of CAN exist, and previous research has used cohorts with long-standing diabetes in a hospital setting (3,15,16).”
BackgroundResultSelf-citationCardiac autonomic neuropathy: Risk factors, diagnosis and treatment
Serhiyenko, V. A., & Serhiyenko, A. A. (2018) · World Journal of Diabetes · doi:10.4239/wjd.v9.i1.1 · Cited by 251
GRuttenfor the ADDITION Study Group, Lauritzen, T., Griffin, S., Borch-Johnsen, K., Wareham, N., & Wolffenbuttel, B. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801420 · Cited by 249
Self-citationAndersen, S. T., Witte, D. R., Dalsgaard, E.-M., Andersen, H., Nawroth, P., Fleming, T., Jensen, T. M., Finnerup, N. B., Jensen, T. S., Lauritzen, T., et al. (2018) · Diabetes Care · doi:10.2337/dc17-2062 · Cited by 248
Self-citationRecommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy☆
Spallone, V., Bellavere, F., Scionti, L., Maule, S., Quadri, R., Bax, G., Melga, P., Viviani, G. L., Esposito, K., & Morganti, R. (2011) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.07.005 · Cited by 243
Methods of investigation for cardiac autonomic dysfunction in human research studies
Bernardi, L., Spallone, V., Stevens, M., Hilsted, J., Frontoni, S., Pop‐Busui, R., Ziegler, D., Kempler, P., Freeman, R., Low, P., et al. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1224 · Cited by 176
Self-citationPop-Busui, R., Braffett, B. H., Zinman, B., Martin, C., White, N. H., Herman, W. H., Genuth, S., Gubitosi-Klug, R., & the DCCT/EDIC Research Group (2017) · Diabetes Care · doi:10.2337/dc16-1397 · Cited by 116
Self-citationSandbæk, A., Griffin, S. J., Rutten, G. E. H. M., Davies, M. J., Stolk, R. P., Khunti, K., Borch‐Johnsen, K., Wareham, N. J., & Lauritzen, T. (2008) · Diabetologia · doi:10.1007/s00125-008-1013-0 · Cited by 108 · cited 2×
“further significant risk factor associations (31,32).”
BackgroundSelf-citationWhat Do We Know and We Do Not Know About Cardiovascular Autonomic Neuropathy in Diabetes
Pop-Busui, R. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9367-6 · Cited by 100 · cited 1×
“Most important are b-blockers, which may increase both CART levels and HRV (8,36).”
BackgroundSelf-citationVoulgari, C., Psallas, M., Kokkinos, A. D., Argiana, V., Katsilambros, N. L., & Tentolouris, N. (2010) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2010.06.001 · Cited by 91
Ayad, F., Belhadj, M., Pariès, J., Attali, J. R., & Valensi, P. E. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03027.x · Cited by 77
An Overview of the Effect of Weight Loss on Cardiovascular Autonomic Function
Maser, R. E., & Lenhard, M. J. (2007) · Current Diabetes Reviews · doi:10.2174/157339907781368931 · Cited by 73
Sandbæk, A., Griffin, S. J., Sharp, S. J., Simmons, R. K., Borch‐Johnsen, K., Rutten, G. E. H. M., van den Donk, M., Wareham, N. J., Lauritzen, T., Davies, M. J., et al. (2014) · Diabetes Care · doi:10.2337/dc13-1544 · Cited by 71 · cited 1×
“General practices were randomized to deliver either intensive, target-driven, multifactorial care or routine care until the trial concluded in 2009 (;6 years after inclusion) (19,20).”
MethodSelf-citationCharles, M., Fleischer, J., Witte, D. R., Ejskjær, N., Borch‐Johnsen, K., Lauritzen, T., & Sandbæk, A. (2012) · Diabetologia · doi:10.1007/s00125-012-2744-5 · Cited by 66 · cited 5×
“Outcome Measures The primary outcome measure was CAN status; CAN was defined by using the gold standard CARTs (5): normal CARTs = no CAN, one abnormal CART = early and reversible CAN, two or three abnormal CARTs = manifest CAN (18).”
BackgroundMethodInfluentialSelf-citationMoran, A. E., Palmas, W., Field, L., Bhattarai, J., Schwartz, J. E., Weinstock, R. S., & Shea, S. (2004) · Diabetes Care · doi:10.2337/diacare.27.4.972 · Cited by 64
Screening for Diabetic Cardiac Autonomic Neuropathy Using a New Handheld Device
Gulichsen, E. H., Fleischer, J., Ejskjær, N., Eldrup, E., & Tarnow, L. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600430 · Cited by 46 · cited 1×
“Engineering, Aarhus, Denmark) at the 6-year examination, and all test centers did so at the 13-year examination (22,23).”
BackgroundSelf-citationRisk-Factor Trajectories Preceding Diabetic Polyneuropathy: ADDITION-Denmark
Andersen, S. T., Witte, D. R., Andersen, H., Bjerg, L., Bruun, N. H., Jørgensen, M. E., Finnerup, N. B., Lauritzen, T., Jensen, T. S., Tankişi, H., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0392 · Cited by 38 · cited 2×
“further significant risk factor associations (31,32).”
BackgroundSelf-citationA Pocket-Size Device to Detect Autonomic Neuropathy
Ejskjær, N., Fleischer, J., Fleischer, J., Jakobsen, P. E., Poulsen, P. L., & Nygaard, H. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200421 · Cited by 26 · cited 3×
“Food and Drug Administration guidelines, and the device has been tested against a stationary device (22).”
BackgroundSelf-citationSelf-Monitoring of Cardiac Autonomic Function at Home is Feasible
Fleischer, J., Nielsen, R. R., Laugesen, E., Nygaard, H., Poulsen, P. L., & Ejskjær, N. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500115 · Cited by 23
Self-citationFleischer, J., Cichosz, S. L., Jakobsen, P. E., Yderstræde, K. B., Gulichsen, E. H., Nygaard, H., Eldrup, E., Lervang, H. H., Tarnow, L., & Ejskjær, N. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814567226 · Cited by 17
Self-citation
Research works printed but not linked: 2
- Cardone, 1990, I test che valutano la risposta riflessa cardiovascolare. Neuropatia diabetica, Rassegna Bibliografica, 2, 151
- Pop-Busui, 2017, Cardiovascular autonomic neuropathy and cardiovascular outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study, 94
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Self-citationSpallone, V. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0259 · Cited by 295
“tes in Primary Care (ADDITION) study, 299 patients were evaluated for CAN at 6 and 13 years [27].”
BackgroundInfluentialPicard, M., Tauveron, I., Magdasy, S., Benichou, T., Bagheri, R., Ugbolue, U. C., Navel, V., & Dutheil, F. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251863 · Cited by 130
Cardiovascular autonomic neuropathy in diabetes: an update with a focus on management
Eleftheriadou, A., Spallone, V., Tahrani, A. A., & Alam, U. (2024) · Diabetologia · doi:10.1007/s00125-024-06242-0 · Cited by 122
CrossTalk proposal: Heart rate variability is a valid measure of cardiac autonomic responsiveness
Malik, M., Hnatkova, K., Huikuri, H. V., Lombardi, F., Schmidt, G. P., & Zabel, M. (2019) · The Journal of Physiology · doi:10.1113/jp277500 · Cited by 106
“Numerous publications showed the clinical value of HRV in the early detection and type-classification of diabetic neuropathy (Howorka et al. 1998; Osterhues et al. 1998; Jirkovská et al. 2006; Andersen et al. 2018).”
Background
Metadata
- Authors
- Andersen, S. T., Witte, D. R., Fleischer, J., Andersen, H., Lauritzen, T., Jørgensen, M. E., Jensen, T. S., Pop-Busui, R., & Charles, M.
- Affiliations
- Aarhus University (DK)
- Aarhus University Hospital (DK)
- University of Southern Denmark (DK)
- Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI
- Corresponding author
- Andersen, Signe T.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2018-10-10
- Volume
- 41
- Issue
- 12
- Pages
- 2586-2594
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2895929992
- Cited by
- 99
- References
- 35
- Citations by year
- 2026: 4 · 2025: 13 · 2024: 13 · 2023: 16 · 2022: 13 · 2021: 17 · 2020: 11 · 2019: 12
- FWCI
- 7.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Funders
- Steno Diabetes Center Copenhagen (SDCC 3. B Epidemiology)
- Novo Nordisk Fonden (NNF14OC0011633, NNF14OC0008981)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- cardiac autonomic neuropathy, type 2 diabetes, cardiometabolic risk factors, cardiovascular autonomic reflex tests, heart rate variability, HbA1c, hyperglycemia, obesity, body mass index, hypertriglyceridemia, disease progression
- MeSH terms
- Aged, Autonomic Nervous System Diseases, Cardiovascular Diseases, Denmark, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Diabetic Neuropathies, Female, Follow-Up Studies, Heart Rate, Humans, Male, Middle Aged, Obesity, Risk Factors, Prevalence, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.